INCOME STATEMENT (Quarterly GAAP In millions $) |
(Sep 30 2022) III. Quarter |
(Jun 30 2022) II. Quarter |
(Mar 31 2022) I. Quarter |
(Dec 31 2021) IV. Quarter |
(Sep 30 2021) III. Quarter |
Revenue From Contract With Customer Including Assessed Tax |
1.50 |
1.32 |
0.97 |
|
0.71 |
Revenue From Contract With Customer Including Assessed Tax |
- |
- |
- |
|
- |
Other Revenue |
- |
-0.34 |
0.00 |
|
- |
Total Revenue |
1.50 |
0.99 |
0.97 |
0.89 |
0.71 |
Cost of Goods and Services Sold |
0.75 |
0.36 |
0.44 |
0.57 |
0.36 |
Gross
Profit |
0.75 |
0.62 |
0.52 |
0.32 |
0.35 |
Selling, Administration, Marketing |
1.42 |
1.59 |
1.84 |
1.40 |
1.46 |
Depriciation & Amortization |
- |
- |
- |
- |
- |
Research and Development Expense |
0.27 |
0.36 |
0.39 |
0.34 |
0.34 |
Asset Impairment Charges |
- |
- |
- |
- |
- |
Other operatinig exp. /-income |
0.00 |
- |
- |
- |
0.00 |
Unusual Expense /-Income |
- |
- |
- |
- |
- |
Total operating costs including COS |
2.44 |
2.31 |
2.68 |
2.31 |
2.17 |
Operating income/-loss
|
-0.94 |
-1.32 |
-1.71 |
-1.42 |
-1.46 |
Other Deductions / - Income |
Interest expense |
0.01 |
0.02 |
0.01 |
0.03 |
0.03 |
Interest income |
- |
- |
- |
- |
- |
Net interest expense/-income |
0.01 |
0.02 |
0.01 |
0.03 |
0.03 |
Loss/ -Gain on Investment |
- |
- |
- |
- |
- |
Foreign Currency Transaction (Gain) Loss |
- |
- |
- |
- |
- |
Allowances, Health Care Trust Fund And Other |
- |
- |
- |
- |
- |
Unexpected (Gain) Loss |
- |
- |
- |
- |
- |
Other loss/ -income |
-0.11 |
0.00 |
-0.18 |
-6.64 |
-0.05 |
Tax Credit Income |
- |
- |
- |
-0.04 |
- |
Impairment Expense Nonoperating |
- |
- |
- |
0.34 |
- |
Profit Loss Including Deemed Dividends For The Change Accounting For Derivative Liability |
- |
- |
- |
1.79 |
- |
Deemed Dividend For The Change In Accounting For Derivative Liability |
- |
- |
- |
-0.74 |
- |
Total costs & expenses |
2.35 |
2.32 |
2.51 |
2.68 |
2.15 |
Income /-loss before income taxes |
-0.85 |
-1.33 |
-1.54 |
-1.79 |
-1.44 |
Income taxes expenses/-benefit |
- |
- |
- |
- |
- |
Income after income taxes |
-0.85 |
-1.33 |
-1.54 |
-1.79 |
-1.44 |
Net income/-loss
of other equity |
- |
- |
- |
- |
- |
Income/-loss
from cont. Ops. |
-0.85 |
-1.33 |
-1.54 |
-1.79 |
-1.44 |
Accounting change |
- |
- |
- |
- |
- |
Discontinued operations |
- |
- |
- |
- |
- |
Extraordinary items |
- |
- |
- |
- |
- |
Net Income/-loss |
-0.85 |
-1.33 |
-1.54 |
-1.79 |
-1.44 |
Noncontrolling interests |
- |
- |
- |
- |
- |
Prefered dividends |
- |
- |
- |
- |
- |
Other |
- |
- |
- |
- |
- |
Income/-loss to shareholder |
-0.50 |
-1.23 |
-1.65 |
-2.53 |
-1.30 |
EBIT |
-0.83 |
-1.32 |
-1.53 |
-1.77 |
-1.41 |
EBITD |
-0.81 |
-1.31 |
-1.53 |
-1.76 |
-1.40 |
EBITDA |
-0.81 |
-1.31 |
-1.53 |
-1.76 |
-1.40 |